Abstract:Background and purpose: Human papilloma virus-associated oropharyngeal squamous cell carcinoma (OPSCC-HPV) is a distinct entity with a significantly increasing incidence. This study aimed to observe the clinicopathological features of OPSCC-HPV. Methods: The clinical characteristics, histological morphology and immunohistochemical phenotypes of 64 cases of OPSCC-HPV who were diagnosed in Fudan University Shanghai Cancer Center from October 2013 to July 2019 were analyzed. The status of HPV and Epstein-Barr virus (EBV) in tumor tissue was detected respectively by polymerase chain reaction (PCR) and in situ hybridization. Results: There were 50 male and 14 female patients, with the age at presentation ranging from 33 to 76 years. The tonsil was the most frequently involved site, followed by the oropharyngeal wall and the base of tongue. A total of 36 patients presented with a progressively enlarged neck mass as an initial symptom, and 57 patients had cervical lymph node metastases (30 with cystic changes). The overall TNM clinical staging of American Joint Committee on Cancer (AJCC) were obtained in 55 cases. Compared to the 7th edition staging rules, the 8th edition overall clinical staging was significantly degraded. Fifty-two cases and 3 cases were diagnosed as stage Ⅰ-Ⅱ and Ⅲ, respectively. Proportion of stage Ⅰ-Ⅱ disease increased by 85.4%, and stage Ⅲ and Ⅳ diseases reduced by 52.7% and 32.7%, respectively. The consistency rate of the 7th and 8th edition clinical TNM staging was only 3.6% (2/55). During the follow-up time ranging from 2 months to 77 months, 2 patients developed local recurrence, 6 patients had cervical lymph node metastasis and 3 patients died. Sixty-three cases were non-keratinizing squamous cell carcinoma (SCC) and 1 case was adenosquamous carcinoma. Tumor cells displayed a high nuclear/cytoplasmic ratio and increased mitotic activity. Immunohistochemical staining showed that P16 was diffusely and strongly positive in 59 of 60 tested cases, and Ki-67 proliferation index was high in 24 cases. High-risk virus infection was found in all 39 patients with HPV-16 type accounting for 92.3%. A total of 35 patients underwent P16 and HPV tests simultaneously with a consistency of 97.1%. Conclusion: OPSCC-HPV has unique clinicopathological features. P16 or HPV detection should be performed on all primary OPSSC and cervical lymph node metastasis of unknown primary.

Parotid squamous cell carcinoma metastases: Application of human papillomavirus ‐DNA test on liquid‐based cytology to recognize oropharyngeal origin of the neoplasm

Human Papillomavirus and Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region: A Comprehensive Review on Clinical Implications

Human papillomavirus circulating tumor DNA: a diagnostic tool in squamous cell carcinoma of unknown primary—a pilot study

Assessing the feasibility of a multimodal liquid biopsy for the diagnosis of HPV-associated oropharyngeal squamous cell carcinoma

Metastases to the parotid glands: An institutional experience

HPV Detection in Head and Neck Squamous Cell Carcinomas: What Is the Issue?

DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW

Diagnostic utility of high‐risk human papillomavirus mRNA in situ hybridisation in squamous cell carcinoma of unknown primary in the head and neck and implementing American Society of Clinical Oncology guideline recommendations

Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients

Mutation and Transcriptional Profiling of Formalin-Fixed Paraffin Embedded Specimens as Companion Methods to Immunohistochemistry for Determining Therapeutic Targets in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Pilot of Proof of Principle

HPV Detection Methods in Head and Neck Cancer

Preliminary Results from Retrospective Correlation of Circulating Tumor DNA (ct-DNA) with Imaging for HPV-positive Oropharyngeal Squamous Cell Carcinoma

Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study

The Next Chapter in Cancer Diagnostics: Advances in HPV-Positive Head and Neck Cancer

Comprehensive Next Generation Sequencing Reveals that Purported Primary Squamous Cell Carcinomas of the Parotid Gland are Genetically Heterogeneous

Diagnostic Accuracy of Circulating Tumor HPV DNA Testing in Patients With a Lateral Neck Mass

Human Papillomavirus in Metastatic Lymph Nodes from Unknown Primary Head and Neck Squamous Cell Carcinoma

HPV-associated oropharyngeal cancer: in search of surrogate biomarkers for early lesions

Circulating tumor HPV DNA in the management of HPV+ oropharyngeal cancer and its correlation with MRI

Analysis of clinicopathological features of human papilloma virus-associated oropharyngeal squamous cell carcinoma

Circulating HPV Tumor DNA and Molecular Residual Disease in HPV-Positive Oropharyngeal Cancers: A Scoping Review